Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Faye A. Luscombe"'
Autor:
Faye A Luscombe
Publikováno v:
Value in Health. 3:S15-S28
Type 2 diabetes has significant adverse effects on health-related quality of life (HRQoL). A vast array of questionnaires has been used to measure HRQoL in diabetes patients, contributing to the difficulty of selecting instruments for future research
Autor:
Faye A. Luscombe
Publikováno v:
Quality of Life Research. 9:161-176
Irritable Bowel Syndrome (IBS) is a chronic recurring disorder with variable illness episodes that may continue for many years. Diagnosis is based on symptoms such as abdominal pain and irregular bowel habits. These symptoms, plus the influence of ps
Autor:
Dale Kraemer, Margaret J. Knapp, James P. Symons, Richard DeJong, William G. Berghoff, Mark W Pierce, Sandra J. Lobbestael, Faye A. Luscombe, Stephen I. Gracon, Stuart L. Dombey
Publikováno v:
Alzheimer Disease & Associated Disorders. 12:93-101
The safety of tacrine (Cognex), a centrally active, reversible acetylcholinesterase inhibitor approved in 1993 for the treatment of mild to moderate dementia of the Alzheimer type, was evaluated in 2,706 patients with Alzheimer disease (AD) in clinic
Publikováno v:
Pharmacoepidemiology and Drug Safety. 6:409-416
A Treatment IND (TIND) is a mechanism available to the Food and Drug Administration (FDA) in the United States by which promising new drugs can be provided to patients with life-threatening illnesses. In many instances, the illness is life-threatenin
Publikováno v:
Archives of Neurology. 54:878-885
To determine whether neurological and psychiatric symptoms predict survival time among patients with Alzheimer disease (AD) after adjusting for the influence of sociodemographic variables, health conditions, and dementia severity separately for men a
Autor:
Faye A. Luscombe, Raymond J. Townsend, Josephine Mauskopf, Jane T. Osterhaus, Joel Bobula, Kevan Clemens
Publikováno v:
PharmacoEconomics. 8:169-174
In January 1995, the Pharmaceutical Research and Manufacturers of America (PhRMA) adopted a voluntary set of principles to provide guidance for its member companies on the conduct and evaluation of pharmacoeconomic research. The principles were prepa
Autor:
Gerry Oster, Faye A. Luscombe, Helene Levens Lipton, Sushil K. Sharma, Robert E. Vestal, Harry Guess
Publikováno v:
Clinical pharmacology and therapeutics. 50(5 Pt 2)
Publikováno v:
Drug Information Journal. 30:839-840
Publikováno v:
Drug Information Journal. 31:1405-1405
Publikováno v:
Journal of Infectious Diseases. 142:363-371
Death rates due to Reye's syndrome and related diseases among children in Michigan were estimated from 1969 to mid-1977 on the basis of searches of death certificates, with verification of diagnosis by review of hospital records. There was no signifi